Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (2016 - 2026)

Catalyst Pharmaceuticals filings provide 15 years of Cash from Investing Activities readings, the most recent being -$27000.0 for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities changed N/A to -$27000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$85000.0, a 76.19% increase, with the full-year FY2025 number at -$58000.0, up 89.57% from a year prior.
  • Cash from Investing Activities hit -$27000.0 in Q1 2026 for Catalyst Pharmaceuticals, up from -$32000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$10000.0 in Q2 2024 to a low of -$162.4 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$132000.0 (2022), compared with a mean of -$26.8 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 70215.91% in 2023 and later soared 99.88% in 2024.
  • Catalyst Pharmaceuticals' Cash from Investing Activities stood at -$132000.0 in 2022, then crashed by 28928.79% to -$38.3 million in 2023, then skyrocketed by 99.77% to -$88000.0 in 2024, then soared by 63.64% to -$32000.0 in 2025, then increased by 15.62% to -$27000.0 in 2026.
  • The last three reported values for Cash from Investing Activities were -$27000.0 (Q1 2026), -$32000.0 (Q4 2025), and -$26000.0 (Q2 2025) per Business Quant data.